Anti-VIM (Pritumumab)-MC-MMAF ADC

• Description:

  This ADC product is comprised of an anti-VIM monoclonal antibody conjugated via a MC linker to MMAF. The MMAF is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.

• Format:

  Solution

• Shipping Conditions:

  Ice Packs

• Storage Conditions:

  -20°C

• CAS Number:

  9007-83-4